Suppr超能文献

饮酒与慢性病毒性肝炎患者死亡风险:一项全国性队列研究。

Alcohol Intake and Mortality in Patients With Chronic Viral Hepatitis: A Nationwide Cohort Study.

机构信息

Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, South Korea.

出版信息

Am J Gastroenterol. 2021 Feb 1;116(2):329-335. doi: 10.14309/ajg.0000000000000966.

Abstract

INTRODUCTION

We evaluated the association between alcohol intake and all-cause and cause-specific mortality in subjects with chronic viral hepatitis, using nationwide population-based cohort study.

METHODS

A total of 364,361 men and women aged 40-84 years who underwent health screening examination between January 2002 and December 2013 that included assessment of frequency and amount of alcohol consumption were assessed for all-cause and cause-specific mortality.

RESULTS

In participants without chronic viral hepatitis, the fully adjusted hazard ratios (HRs) for all-cause mortality comparing light, moderate, and heavy drinkers with nondrinkers were 0.92 (95% confidence interval [CI] 0.87-0.98), 1.08 (95% CI 1.01-1.16), and 1.51 (95% CI 1.33-1.72), respectively. In participants with chronic viral hepatitis, the corresponding HRs were 1.19 (95% CI 1.05-1.36), 1.23 (95% CI 1.06-1.43), and 1.69 (95% CI 1.28-2.24), respectively (P value for alcohol intake by chronic viral hepatitis interaction <0.001). Compared with participants without chronic viral hepatitis, those with chronic viral hepatitis had substantially elevated liver cancer or liver disease (HR 10.85, 95% CI 9.74-12.09) and extrahepatic cancer mortality (HR 1.37, 95% CI 1.26-1.49). In patients with chronic viral hepatitis, the high mortality due to liver cancer or liver disease and the positive association of alcohol intake with liver cancer or liver disease mortality explained the positive association of alcohol intake with all-cause mortality.

DISCUSSION

Even light to moderate alcohol intake was associated with increased all-cause mortality in individuals with chronic viral hepatitis. Clinicians and public health campaigns should advise against any amount of alcohol intake in individuals with chronic viral hepatitis.

摘要

介绍

我们通过全国性的基于人群的队列研究,评估了饮酒与慢性病毒性肝炎患者全因和死因特异性死亡率之间的关系。

方法

共有 364361 名年龄在 40-84 岁之间的男性和女性参加了 2002 年 1 月至 2013 年 12 月期间的健康筛查检查,包括评估饮酒频率和量,对全因和死因特异性死亡率进行评估。

结果

在没有慢性病毒性肝炎的参与者中,与不饮酒者相比,轻、中、重度饮酒者的全因死亡率的完全调整后的危险比(HR)分别为 0.92(95%置信区间[CI] 0.87-0.98)、1.08(95%CI 1.01-1.16)和 1.51(95%CI 1.33-1.72)。在患有慢性病毒性肝炎的参与者中,相应的 HR 分别为 1.19(95%CI 1.05-1.36)、1.23(95%CI 1.06-1.43)和 1.69(95%CI 1.28-2.24)(慢性病毒性肝炎交互作用的酒精摄入 P 值<0.001)。与没有慢性病毒性肝炎的参与者相比,患有慢性病毒性肝炎的参与者肝癌或肝病(HR 10.85,95%CI 9.74-12.09)和肝外癌症死亡率(HR 1.37,95%CI 1.26-1.49)显著升高。在患有慢性病毒性肝炎的患者中,由于肝癌或肝病导致的高死亡率以及饮酒与肝癌或肝病死亡率之间的正相关关系,解释了饮酒与全因死亡率之间的正相关关系。

讨论

即使是轻度到中度的饮酒也与慢性病毒性肝炎患者的全因死亡率增加有关。临床医生和公共卫生运动应该建议慢性病毒性肝炎患者不要饮酒。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验